Cargando…
Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease
The lack of reliable biomarkers is a significant challenge impeding progress in orphan drug development. For appropriate interpretation of intervention-based results or for evaluating candidate biomarkers, other things being equal, lower variability in biomarker measurement would be helpful. However...
Autores principales: | Sahasrabudhe, Siddhee A., Terluk, Marcia R., Rudser, Kyle D., Cloyd, James C., Kartha, Reena V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409136/ https://www.ncbi.nlm.nih.gov/pubmed/36012454 http://dx.doi.org/10.3390/ijms23169189 |
Ejemplares similares
-
N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2023) -
Patients with Gaucher disease display systemic oxidative stress dependent on therapy status
por: Kartha, Reena V., et al.
Publicado: (2020) -
Modeling potential interactions between oral Gaucher disease treatment and investigational COVID-19 therapies
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2021) -
N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy
por: Zhou, Jie, et al.
Publicado: (2021) -
Identifying Biological Signatures of N-Acetylcysteine for Non-Suicidal Self-Injury in Adolescents and Young Adults
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2021)